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We report the application of the arsenical complex FlAsH-EDT2 for the identification of 
oligonucleotide sequences. We designed PNA sequences conjugated to either a tetracysteine 
motif and to split tetracysteine sequences, that are recognized by FlAsH. The effect of 
conjugation of the PNA to the tetracysteine peptide and RNA hybridization on the fluorescence 
of the arsenical complex has been investigated. The reconstitution of the tetracysteine motif, 
starting from 15-mer PNAs conjugated to split tetracysteine sequences and hybridized to a 
complementary oligonucleotide was also explored. 
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Introduction 
Recent discoveries in the field of non-coding RNAs (ncRNAs) have greatly promoted the research 
of tools to detect, localize and monitor RNA molecules in living cells using fluorescent probes[1]. A 
number of strategies have been developed so far, based on the recognition of RNA sequences by 
fluorescent RNA binding proteins, RNA binding fluorescent tags or by complementary 
oligonucleotides bearing a fluorescent tag. When fluorescent probes are conjugated or 
incorporated into oligonucleotide sequences, hybrids can easily be detected; multiple fluorescent 
probes are usually employed to increase brightness. The background fluorescence of the proteins 
or of the probes limits the application of these systems. Fluorescent probes sensitive to the 
polarity of the environment are widely employed to reveal hybridization processes. These probes 
are often covalently linked to the sugar portion of one nucleotide[2,3] and exhibit intense 
fluorescence upon hybridization to the targets, while very weak fluorescence when installed on 
single strands. Thiazole Orange (TO) is an example of light-up probe which has been demonstrated 
useful for the imaging of RNA/DNA counterparts in vitro and in vivo[4,5,6]. The use of metal 
complexes for the imaging of oligonucleotide is little explored. Radiolabeled PNA have been 
obtained and tested in vivo for radiopharmaceutical applications[7,8]. Luminescent Ru(I) 
complexes have been covalently linked at the N-terminus of peptide nucleic acid (PNA) oligomers; 
emission properties of the metal complexes do not change upon conjugation of the complex to 
the PNA oligomer and/or hybridization [9,10].  
Peptides can also be employed as metal ligands. Metal complexes showing high specificity of 
binding toward specific peptide sequences have been reported [11,12,13,14]. The most successful 
example of metal complex exhibiting high affinity of binding toward a specific peptide sequence is 
represented by the 4’,5’-bis(1,3,2-dithioarsolan-2-yl)fluorescein, namely FlAsH EDT2[15]. FlAsH-
EDT2 is of great interest due to its brightness, selectivity toward the tetracysteine motif, ability to 
be taken up by cells[15]; it lights up upon complexation of the arsenic moiety to the tetracysteine 
motif and following displacement of the two 1,2 etanedithiol (EDT) molecules. Proteins bearing 
the tetracysteine motif can be identified in cellular systems with high sensitivity [16,17]. 
Interestingly, the tetracysteine motif can be split in two halves: when the two halves come close in 
the space, reconstitution of the tetracysteine motif occurs and this can be revealed by the 
fluorescence of the biarsenical complex. In this context, the FlAsH-EDT2 may be used as a probe to 
detect either dimerization of two proteins and structural rearrangements of two protein domains, 
each linked to a half of the tetracysteine motif[18,19]. Analogous applications have been reported 
for resourcine-arsenical (ReAsH) complexes[20,21,22]. 
In this work, we explored the use of FlAsH-EDT2 for the recognition of PNA/RNA and PNA/DNA 
hybrids. PNA oligomers are conjugated to a peptide sequence (“full” and “split”) that is specifically 
recognized by FlAsH-EDT2; when the split peptide is employed, the reconstitution of the 
tetracysteine motif is DNA templated. The high stability to degradation in vivo of PNAs, the high 
affinity and specificity of binding of PNA towards complementary DNA and RNA, together with the 
brightness and the cell permeability of the FlAsH complexes render this strategy very promising for 
the imaging of oligonucleotides[23,24,25]. We investigated the effect of conjugation of the PNA to 
the tetracysteine peptide on the fluorescence of the complex formed upon interaction of the 
FlAsH-EDT2 with the tetracysteine peptide. We also monitored the effect of hybridization to RNA 
oligomers on the fluorescence of the PNA conjugated to the tetracysteine peptide and complexed 
with FlAsH . The PNA-tetracysteine conjugate was designed to target miR-17-5p while the PNAs 
conjugated to the split tetracysteine motifs target MYCN. Both targets are highly expressed in 
neuroblastoma (NB) cells and therefore useful as markers for NB[26,27]  
 
Materials and Methods  
Peptide and peptide-PNA conjugates synthesis. See Supplementary materials 
 
Fluorescence Experiments.  
 
The FlAsH-EDT2 dye was prepared according to procedures described in the literature[25]. NMR 
and mass spectrometry results are consistent with those reported in the literature. Fluorescence 
experiments were performed according to published procedures [25].  
Fluorescence experiments were carried out monitoring the fluorescence intensity at 530 nm upon 
excitation at 508 nm. Each experiment was performed in a buffer solution of 10mM aqueous 
solution of 3-morpholinopropane-1-sulfonic acid (MOPS) neutralized with NaOH to pH 7.2 and 
degassed. The fluorescence of the complex formed by FlAsH with the peptide 4C was measured at 
0.5 and 1 M concentration. The concentration of PNA a17 4C, PNA a17 4C/RNA duplexes is 
0.5M, the concentration of the PNAs R8-PNA1 2C-C, N-2C-PNA2-R8 and of the corresponding 
duplexes with DNA is 1 M. PNA/RNA (or DNA) duplexes were obtained mixing 10 μM of PNA and 
10 μM of complementary RNA (or DNA) in MOPS buffer 100 mM, pH 7.2. The annealing reaction 
was performed by warming up to 90°C for 5 min, slowly cooling down to 4°C. Duplexes were kept 
at 4°C overnight before use. All experiments were repeated in duplicate.  
Experiments were carried out as follows:   
to 2.5 mL of the MOPS buffer in a fluorescence cuvette, were added 25 L of MESNa (1M in H2O) 
followed by 2.5 L of EDT (10 mM in dry DMSO) to give final concentrations of MESNa and EDT of 
10 mM and 10 M respectively and FlAsH-EDT2 (from a 2mM stock solution prepared in dry 
DMSO). The final concentration of FlAsH-EDT2 is,  identical to that of the oligonucleotide  added 
(0.5 or 1 M). The fluorescence is measured every 5 min for 15-20 min or till the value stays 
constant. 
Next single strand PNA (PNA a17 4C or R8-PNA1 2C-C + N-2C-PNA2-R8) or duplexes (PNA a17 
4C/miR-17-5p or R8-PNA1 2C-C + N-2C-PNA2-R8/MYCN or N-2C-PNA2-R8 /MYCN) are added and 
the fluorescence measured every 15 min for the following 3 hours. 
 
In a different experiment an equimolar amount of the miR-17-5p or the miR-17-5p mismatch 1, 
miR-17-5p mismatch 2 or miR-17-5p mismatch 3 was added to the solution of PNA-a17-4C+ FlAsH 
in MOPS EDT, prepared as described earlier.  
Other control experiments were carried out measuring the fluorescence of solution obtained 
adding to the MESNa+EDT solution in MOPS the tetracysteine peptide 4C or miR17-5p (to be sure 
that the FlAsH does not interact with the RNA). 
 
Results and discussion 
Design and synthesis of PNA-peptide conjugates. The detection of DNA and RNA targets 
designated as markers of human diseases requires the development of probes highly sensitive. In 
this work, we investigated the ability of PNA conjugated to the peptide motif recognized by the 
arsenical complex FlAsH-EDT2 and hybridized to complementary RNA and DNA sequences to light 
up upon formation of the metal complex. 
We designed molecules for the imaging of miR-17-5p and of MYCN mRNA (Fig 1A).The molecules 
are composed of a PNA module, devoted to the recognition of the RNA target and a peptide motif 
which selectively recognizes and lights up the fluorophore FlAsH-EDT2 upon displacement of the 
EDT molecules by the four cysteines motif[28]. For the recognition of miR-17-5p we designed a 23-
mer PNA perfectly complementary to miR-17-5p and conjugated at the N terminus to the peptide 
PEMCCGPCCNLF (4C, “full” peptide sequence); the conjugate is named PNA a17 4C (Table 1). For 
the recognition of MYCN mRNA we envisioned the use of two 15-mer PNA oligomers, each 
conjugated to one of the halves of the tetracysteine motif (“split” peptide sequence) (Fig 1B) 
(Table 1). Conjugation of these PNAs to a polyarginine (R8) peptide is thought to be an effective 
strategy for enhancing cellular permeability for future in vitro and in vivo applications. The 
sequences of the “split” peptides are: PEMCC (2C-C) and CCNLF (N-2C). The two PNAs are 
complementary to contiguous region of the mRNA and, following hybridization to the mRNA, 
should enable the reconstitution of the tetracysteine peptide motif by allowing the cysteine 
residues to come close into space. The PNAs are named R8-PNA1 2C-C, when the polyarginine is 
conjugated at the N-terminus and the split tetracysteine motif (2C-C) is at the C-terminus of the 
PNA, and N-2C-PNA2-R8 when the polyarginine is at the C-terminus of the PNA and the split 
tetracysteine peptide (N-2C) is at the N-terminus of the PNA. Each PNA (PNA1 and PNA2) is 15 
bases long and together span the region of the N-myc mRNA that begins with the ATG start codon 
at position 1,650[29] This region of the MYCN sequence is reported as efficiently recognized by 
antisense complementary oligonucleotides[30,31,32]. Conjugates were obtained in all case by 
solid phase synthesis, using standard protocols [6,33,34]. 
 
Fluorescence experiments. Fluorescence experiments were performed according to procedures 
described in the literature[25]. We initially monitored the fluorescence emission intensity upon 
excitation at 508 nm of the FlAsH complexes formed with the peptide 4C and the single strand 
PNA-peptide conjugate PNA a17 4C. The fluorescence intensity of the complexes increases with 
the time and becomes stable after 180 minutes of incubation (Fig S1). For this reason we report 
the fluorescence intensity after 180 minutes of incubation of the arsenical complex with our target 
molecules. The FlAsH emission wavelength shifts from 528 nm in the complex with the 
tetracysteine peptide (4C) to 531 nm in the complexes with the PNA-peptide conjugate. We 
calculated the increase in the fluorescence intensity of the complexes with respect to the FlAsH-
EDT2 (i.e. fluorescence of the complex/fluorescence of FlAsH-EDT2). A comparison between the 
fluorescence of the complex FlAsH-4C and FlAsH-PNA a17 4C revealed that the conjugation of the 
peptide to the PNA reduces the fluorescence intensity of the complex of about one third (Fig 2A). 
In fact, we observed a 300 fold increase in the fluorescence for the FlAsH-4C peptide complex and 
a 90 fold increase for the FlAsH-PNA a17 4C complex (Fig 2A). This result may be explained 
considering that conjugation of the PNA to the peptide changes the chemical environment of the 
complex, which in turn affects the fluorescence emission properties of the complex. Formation of 
the hybrid upon addition of miR-17-5p to the complex formed by FlAsH and PNA a17 4C does not 
significantly affect the fluorescence of the complex (Fig 2A). Similarly, hybridization of the RNA 
oligomers miR-17-5p mismatch 1, miR-17-5p mismatch 2 and miR-17-5p mismatch 3 (Table 2), 
which are not perfectly complementary to PNA a17 4C to the complex formed by PNA a17 4C and 
FlAsH, does not change the fluorescence intensity emission of the complex. In fact the ratio 
between the fluorescence of the complexes before and after hybridization is comparable (Fig 2B), 
demonstrating that the complex is very stable and its properties are not affected by the stability of 
the duplexes. It is indeed expected that the insertion of mismatches reduces the thermal stability 
of the duplexes. 
Next we investigated the complexation of FlAsH-EDT2 to PNA/RNA duplexes obtained by annealing 
the PNA and RNA strands (Fig 2C). The fluorescence intensity of the complexes in this case is lower 
as compared to the fluorescence intensity of the complexes obtained hybridizing the RNA to the 
PNA a17 4C-FlAsH complex (compare Fig 2C and Fig 2A) and this is likely due to the steric and 
electronic effects imposed by the presence of the duplex which hampers the formation of the 
metal complex. Also in this case the formation of the complex is independent of the stability of the 
duplexes, within the experimental error. A 53 fold increase in the fluorescence intensity is 
observed when FlAsH is complexed to the duplex PNA a17 4C/miR-17-5p (calculated as 
fluorescence of the duplex/fluorescence of FlAsH EDT2), (Fig 2C). When the PNA a17 4C is 
hybridized to RNA sequences not perfectly complementary, with one to three mismatches, the 
fluorescence signal observed upon complexation of the FlAsH-EDT2 is comparable or slightly lower 
than that observed for the duplex PNA a17 4C/miR-17-5p. The ability to distinguish 
complementary matched and mismatched sequences is in fact low when the PNA oligomers are 
long; on the other side the use of long PNA sequences is dictated by the need to target unique 
RNA or DNA sequences, keeping in mind that the chance that a specific sequence is unique in the 
genome is proportional to its length. We wish to highlight that the observed increase is higher 
than that observed with other probes such as TO attached as a tag at the end of a PNA oligomer[6] 
or perylene or pyrene incorporated into oligonucleotide sequences[3,35]. In the case of TO 
conjugated at the N-terminus of a PNA sequence we observed an increase of only 2.5-3 fold in the 
fluorescence intensity upon hybridization[6]. 
As controls we also measured fluorescence of DNA and RNA single strands mixed with FlAsH-EDT2 
and of duplex hybrids without FlAsH. As expected, single stranded PNA-peptide conjugates, single 
stranded DNA and RNA, duplexes formed between the PNA-peptide conjugates and either DNA 
and RNA oligomers are not fluorescent; also mixtures of DNA or RNA oligomers with FlAsH exhibit 
a very weak fluorescence whose intensity is identical to that shown by the FlAsH-EDT2 complex in 
the same conditions. . 
 
The biarsenical complex was employed to recognize longer oligonucleotide sequences. To this aim, 
we explored the complexation of the FlAsH-EDT2 to the split tetracysteine motif. We used as a 
target a DNA oligomer having the same sequence as the MYCN mRNA and to allow the recognition 
of the longer sequence we used two PNA oligomers, each conjugated to a split tetracysteine motif. 
To grant selectivity we employed PNA sequences 15 bases long. The peptide sequences that have 
been conjugated to the PNAs are: PEMCC and CCNLF. The two PNAs, each conjugated to a split 
tetracysteine motif (namely R8-PNA1 2C-C and N-2C-PNA2-R8), were hybridized to 
complementary oligonucleotides of different length. The reconstitution of the tetracysteine 
sequence is templated and occurs upon hybridization (Fig 3). The hybrids differ for the distance, 
expressed in term of base pairs gap, between the two PNAs on the MYCN DNA. These experiments 
are aimed at finding the most favorable distance between the two PNAs which allows for the 
reconstitution of the tetracysteine motif and its subsequent reaction with FlAsH-EDT2. We used 
DNA sequences instead of RNA sequences, to reduce the cost of our experiments. We assume that 
the difference in the three-dimensional structure of both the PNA/DNA and PNA/RNA duplexes 
does not drastically affect the re-assembly of the tetracysteine ligand. As described earlier, the 
fluorescence intensity of the hybrids was compared to that of the FlAsH-EDT2 complex in buffer. 
When PNAs R8-PNA1 2C-C and N-2C-PNA2-R8 hybridize the complementary oligonucleotide and 
there is no base pair gap between the PNAs, we observe a 38 fold increase in the fluorescence 
intensity upon complexation of FlAsH-EDT2 (Fig 4A). When the base pair gap expands, the increase 
of the fluorescence intensity of the complex is lightly lower. The increase in the fluorescence 
intensity of the complex formed with the split tetracysteine motif is lower than that observed for 
the full tetracysteine motif. In this case, the length of the PNA probes is critical to determine the 
fluorescence of the complexes. In fact, in a recently published paper it is reported that 
hybridization of two 8-mer PNA sequences, equipped with a Pro-Ala-Gly-Cys-Cys peptide to a 
complementary DNA results in a 80 fold increase in the fluorescence intensity as compared to the 
fluorophore[36]. Also, the use of two 8-mer PNAs enables the recognition of one base mismatch 
on the complementary oligonucleotide. 
As a control, we monitored the fluorescence of the mixture of PNAs R8-PNA1 2C-C and N-2C-
PNA2-R8 in the presence of FlAsH-EDT2 and we found that the increase of the fluorescence 
intensity is comparable to that observed for the peptide 4C incubated with the biarsenical 
complex. We also measured the fluorescence of the duplex formed by N-2C-PNA2-R8 and MYCN 
and we observed a weak increase in the fluorescence intensity (Fig 4B). Complexation of FlAsH-
EDT2 occurs only with the reconstituted tetracysteine motif. Importantly, the use of two PNA 
sequences results in an increase in the specificity of the systems, as a larger number of bases need 
to be recognized by the PNAs. 
  
 The results of our studies demonstrate that the FlAsH-EDT2 lights up when the tetracysteine 
peptide is conjugated to a PNA sequence as single strand or hybridized to its complementary 
oligonucleotide.. Results obtained here encourage the application of the tetracysteine motif for 
the detection of oligonucleotide sequences in vivo.  
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Figure 1. Schematic illustration of the PNA-peptide conjugates employed. A: the tetracysteine 
motif (4C) conjugated to the PNA for the recognition of the target miR-17-5p; B: the split 
tetracysteine motif peptides (2C-C and N-2C) are conjugated to PNA oligomers complementary to 




Figure 2. 2A:Effect of conjugation and hybridization on the fluorescence emission of the 
complexes formed by the FlAsH. Fluorescence of the complex peptide 4C +FlAsH (1) is compared 
to the fluorescence of the complexes PNA a17 4C+FlAsH (2) and PNA a17 4C+FlAsH+miR-17-5p (3). 
miR-17-5p is added to the complex of PNA-a17-4C and FlAsH. The fluorescence increase is 
measured as fluorescence of the complex/fluorescence of FlAsH EDT2. The concentration of the 
peptide 4C, the PNA-peptide conjugate PNA a17 4C, miR-17-5p and FlAsH is 0.5M. 2B: Effect of 
the hybridization of the PNA a17 4C-FlAsH complex with the complementary miR-17-5p (1) and 
with mismatched sequences 1,2 and 3 (bar numbers 2,3,and 4). Sequences of the RNA are listed in 
table 2.The fluorescence is expressed as fluorescence of the FlAsH-duplex complex/fluorescence 
of the PNA a17 4C-FlAsH complex. The concentration of the PNA oligomers, the RNA and the 
fluorescent probe is 0.5M. 2C: Complexation of the FlAsH with PNA/RNA duplexes. In this 
experiment the duplexes were first annealed and then the FlAsH-EDT2 complex was added. 1: 
duplex PNA a17 4C/ miR-17-5p; 2: duplex PNA a17 4C/ miR-17-5p mismatch 1; 3: duplex PNA a17 4C/ 
miR-17-5p mismatch 2; 4: duplex PNA a17 4C/ miR-17-5p mismatch 3. The fluorescence increase is 
expressed as fluorescence of the FlAsH-duplex complex/fluorescence of FlAsH-EDT2. The 
concentration of the duplexes and of the FlAsH is 0.5M. 
 
 
Figure 3. Schematic representation of the hybrids formed by the PNAs conjugated to the split 
tetracysteine motif and the complementary DNA sequence. Hybrids differ for the distance 
between the PNA sequences, which affects the distance between the split tetracysteine motifs. 
 
  
Figure 4. 4A:Fluorescence intensity increase of the duplexes formed by the PNAs conjugated to 
the split tetracysteine peptides and oligonucleotides of different length. PNAs are annealed to a 
complementary oligonucleotide with consecutive bases (no gap) (1) or to sequences separated by 
1 (2), 3 (3), 5 (4) to 8 (5) base pair gaps, then the FlASH-EDT2 is added. The increase in calculated as 
fluorescence of the FlAsH-duplex complex/fluorescence of the FlAsH-EDT2. The scheme of the 
hybrids is reported in figure 3. The concentration of the duplexes and of the probe is 1M. 4B: 
Comparison of the fluorescence intensity of the complex formed by the FlAsH with the peptide 4C 
(1), an equimolar mixture of the PNAs R8-PNA1 2C-C+ N-2C-PNA2-R8 (2) , and the hybrid R8-PNA1 
2C-C+ MYCN no gap (3) . The concentration of the PNAs, duplex and peptide is 1M. The 
fluorescence reported for the complex 4C-FlAsH was measured after 120 minutes of incubation of 
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